AVROBIO grants non-statutory stock options to ten new employees under Nasdaq Listing Rule 5635(c)(4).

Global Banking News-April 7, 2021-AVROBIO grants non-statutory stock options to ten new employees under Nasdaq Listing Rule 5635(c)(4)

(C)2021 ENPublishing - http://www.enpublishing.co.uk

Gene therapy company AVROBIO Inc (Nasdaq:AVRO) announced on Tuesday that it has awarded non-statutory stock options for the purchase of up to an aggregate of 140,000 shares of its common stock to ten new employees as inducement awards in accordance with Nasdaq Listing Rule 5635(c)(4).

With a grant date of 1 April 2021, the stock options have an exercise price of USD12.31 per share, representing the closing price of the company's common stock as reported by Nasdaq on the grant date.

The company's stock option awards have...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT